About National HealthCare (NYSEMKT:NHC)
National HealthCare Corporation (NHC) is engaged in the operation of skilled nursing facilities, assisted living facilities, independent living facilities and homecare programs. The Company is engaged in the post-acute healthcare industry segment. Its business activities include providing sub-acute and post-acute skilled nursing care, intermediate nursing care, rehabilitative care, memory and Alzheimer's care, senior living services, and home healthcare services. It has interest in a hospice care business that services NHC owned healthcare centers and others. In addition, it provides management services, accounting and financial services, as well as insurance services to third-party operators of healthcare facilities. As of December 31, 2016, it owned the real estate of 13 healthcare properties and leased these properties to third-party operators. As of December 31, 2016, it operated in 10 states, and its owned and leased properties are located in various parts of the United States.
Industry, Sector and Symbol:
- Sector: Healthcare
- Industry: Residential & Long Term Care
- Sub-Industry: Health Care Facilities
- Symbol: NYSEMKT:NHC
- CUSIP: 63590610
- Web: www.nhccare.com
- Market Cap: $985.7 million
- Outstanding Shares: 15,195,000
- 50 Day Moving Avg: $63.05
- 200 Day Moving Avg: $67.47
- 52 Week Range: $57.73 - $78.99
Sales & Book Value:
- Trailing P/E Ratio: 20.59
- Foreward P/E Ratio: 150.86
- P/E Growth: 0.00
- Annual Revenue: $947.98 million
- Price / Sales: 1.04
- Book Value: $45.32 per share
- Price / Book: 1.43
- Annual Dividend: $1.80
- Dividend Yield: 3.0%
- EBITDA: $101.55 million
- Net Margins: 4.41%
- Return on Equity: 6.26%
- Return on Assets: 3.89%
- Average Volume: 33,912 shs.
- Beta: 0.91
- Short Ratio: 3.45
Frequently Asked Questions for National HealthCare (NYSEMKT:NHC)
What is National HealthCare's stock symbol?
National HealthCare trades on the New York Stock Exchange (NYSE)MKT under the ticker symbol "NHC."
How often does National HealthCare pay dividends? What is the dividend yield for National HealthCare?
National HealthCare announced a quarterly dividend on Friday, August 4th. Investors of record on Friday, September 29th will be paid a dividend of $0.48 per share on Friday, December 1st. This represents a $1.92 dividend on an annualized basis and a yield of 2.96%. The ex-dividend date is Thursday, September 28th. View National HealthCare's Dividend History.
How will National HealthCare's stock buyback program work?
National HealthCare declared that its board has initiated a share buyback program on Wednesday, August 9th 2017, which permits the company to repurchase $25,000,000.00 in shares, according to EventVestor. This repurchase authorization permits the company to buy shares of its stock through open market purchases. Shares repurchase programs are usually a sign that the company's board believes its stock is undervalued.
How were National HealthCare's earnings last quarter?
National HealthCare Co. (NYSEMKT:NHC) issued its quarterly earnings results on Friday, August, 4th. The company reported $0.70 earnings per share (EPS) for the quarter. The firm had revenue of $239.46 million for the quarter. National HealthCare had a return on equity of 6.26% and a net margin of 4.41%. View National HealthCare's Earnings History.
When will National HealthCare make its next earnings announcement?
Who are some of National HealthCare's key competitors?
Some companies that are related to National HealthCare include Dechra Pharmaceuticals plc (DPH), Owens & Minor (OMI), CONMED (CNMD), Acceleron Pharma (XLRN), Genus plc (GNS), Clinigen Group PLC (CLIN), Mazor Robotics Ltd - (MZOR), Knight Therapeutics (GUD), Knight Therapeutics (GUD), Spire Healthcare Group PLC (SPI), Asante Solutions (PUMP), Lexicon Pharmaceuticals (LXRX), ProMetic Life Sciences (PLI), Biohaven Pharmaceutical Holding Co Ltd (BHVN), TherapeuticsMD (TXMD), Epizyme (EPZM), Canfor Pulp Products (CFX) and Albany Molecular Research (AMRI).
Who are National HealthCare's key executives?
National HealthCare's management team includes the folowing people:
- Michael Ussery, President, Chief Operating Officer
- Stephen F. Flatt, Chief Executive Officer, Director
- Brian F. Kidd, Senior Vice President, Principal Accounting Officer, Controller
- B. Anderson Flatt, Senior Vice President, Chief Information Officer
- John K. Lines, Senior Vice President, General Counsel, Secretary
- Jeffrey Russell Smith, Senior Vice President, Treasurer
- Julia Williams Powell, Senior Vice President - Patient Services
- Robert G. Adams, Non-Executive Chairman of the Board
- W. Andrew Adams, Director
- J. Paul Abernathy M.D., Independent Director
Who owns National HealthCare stock?
National HealthCare's stock is owned by many different of institutional and retail investors. Top institutional shareholders include Strs Ohio (0.08%). Company insiders that own National HealthCare stock include David L Lassiter, Ernest G Burgess III, Health Corp National, James Paul Abernathy, Jeffrey Russell Smith, Julia W Powell and Stephen Fowler Flatt. View Institutional Ownership Trends for National HealthCare.
Who bought National HealthCare stock? Who is buying National HealthCare stock?
How do I buy National HealthCare stock?
Shares of National HealthCare can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is National HealthCare's stock price today?
MarketBeat Community Rating for National HealthCare (NYSEMKT NHC)MarketBeat's community ratings are surveys of what our community members think about National HealthCare and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
One share of National HealthCare stock can currently be purchased for approximately $64.87.
Consensus Ratings for National HealthCare (NYSEMKT:NHC) (How are Consensus Ratings Calculated?)
MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
|Ratings Breakdown: ||No ratings tracked in the last 12 months.|
|Consensus Rating:||N/A (Score: NaN)|
|Consensus Price Target: ||N/A|Consensus Price Target History for National HealthCare (NYSEMKT:NHC)
Analysts' Ratings History for National HealthCare (NYSEMKT:NHC)
(Data available from 10/23/2015 forward)
|9/22/2016||Macquarie||Upgrade||Underperform -> Outperform|
Earnings History for National HealthCare (NYSEMKT:NHC)Earnings History by Quarter for National HealthCare (NYSEMKT NHC)
(Data available from 1/1/2011 forward)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|11/2/2017|| || || || || || || || |
|8/4/2017||Q2 2017||$0.70||$239.46 million||View||N/A|
|5/10/2017||Q1 2017||$0.84||$239.24 million||View||N/A|
|2/15/2017||Q4 2016||$0.91||$238.00 million||View||N/A|
|8/6/2015||Q215||$0.71||$216.60 million||$224.90 million||View||N/A|
|2/20/2015||Q414||$0.88||$207.00 million||$226.00 million||View||N/A|
|11/6/2014||Q314||$0.75||$182.97 million||$207.77 million||View||N/A|
|8/6/2014||Q214||$0.72||$192.01 million||$216.56 million||View||N/A|
|5/8/2014||Q114||$0.78||$194.38 million||$210.53 million||View||N/A|
|2/24/2014||Q413||$1.04||$193.98 million||$206.80 million||View||N/A|
|11/6/2013||Q313||$1.28||$189.31 million||$195.77 million||View||N/A|
Earnings Estimates for National HealthCare (NYSEMKT:NHC)
Current Year EPS Consensus Estimate: $2.54 EPS
Next Year EPS Consensus Estimate: $0.43 EPS
Current Dividend Information for National HealthCare (NYSEMKT:NHC)
|Payout Ratio:||52.94% (Trailing 12 Months of Earnings) |
70.87% (Based on This Year's Estimates)
418.60% (Based on Next Year's Estimates)
Dividend History by Quarter for National HealthCare (NYSEMKT NHC)
(Data available from 1/1/2013 forward)
|Announced||Period||Amount||Yield||Ex-Dividend Date||Record Date||Payable Date|
Insider Trading and Institutional Ownership History for National HealthCare (NYSEMKT:NHC)Insider Trades by Quarter for National HealthCare (NYSEMKT:NHC)
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Details|
|9/28/2017||Jeffrey Russell Smith||SVP||Sell||1,848||$62.78||$116,017.44|| |
|6/12/2017||Jeffrey Russell Smith||SVP||Sell||4,000||$72.78||$291,120.00|| |
|2/27/2017||Julia W Powell||VP||Sell||350||$74.47||$26,064.50|| |
|2/24/2017||Julia W Powell||VP||Sell||1,080||$74.43||$80,384.40|| |
|2/22/2017||Julia W Powell||VP||Sell||4,000||$74.48||$297,920.00|| |
|12/21/2016||Ernest G. Burgess III||Director||Sell||8,000||$77.57||$620,560.00|| |
|12/7/2016||James Paul Abernathy||Director||Sell||879||$70.49||$61,960.71|| |
|11/25/2016||James Paul Abernathy||Director||Sell||1,000||$70.00||$70,000.00|| |
|11/18/2016||James Paul Abernathy||Director||Sell||1,000||$69.44||$69,440.00|| |
|9/16/2016||David L Lassiter||Insider||Sell||2,704||$64.50||$174,408.00|| |
|8/5/2016||Health Corp National||Major Shareholder||Sell||130,000||$63.04||$8,195,200.00|| |
|6/16/2016||David L. Lassiter||VP||Sell||5,000||$64.24||$321,200.00|| |
|5/9/2016||David L. Lassiter||VP||Sell||8,000||$64.50||$516,000.00|| |
|11/30/2015||James Paul Abernathy||Director||Sell||1,000||$67.00||$67,000.00|| |
|11/12/2015||Stephen Fowler Flatt||President||Sell||1,000||$65.55||$65,550.00|| |
|11/17/2014||Ernest G Burgess III||Director||Sell||1,000||$60.29||$60,290.00|| |
|11/10/2014||Emil E Hassan||Director||Sell||2,429||$62.21||$151,108.09|| |
|8/22/2014||David L Lassiter||VP||Sell||2,000||$57.10||$114,200.00|| |
|8/11/2014||Health Corp National||Major Shareholder||Sell||125,000||$55.96||$6,995,000.00|| |
|6/5/2014||David L Lassiter||VP||Sell||5,000||$54.73||$273,650.00|| |
|3/17/2014||Emil E Hassan||Director||Sell||2,000||$55.08||$110,160.00|| |
|3/4/2014||Emil E Hassan||Director||Sell||2,149||$55.12||$118,452.88|| |
|2/24/2014||David L Lassiter||VP||Sell||4,000||$49.99||$199,960.00|| |
|11/12/2013||David L Lassiter||VP||Sell||1,000||$49.88||$49,880.00|| |
|11/8/2013||Julia W Powell||VP||Sell||1,531||$50.15||$76,779.65|| |
|11/7/2013||Julia W Powell||VP||Sell||1,100||$49.88||$54,868.00|| |
|9/24/2013||James Paul Abernathy||Director||Sell||1,000||$49.02||$49,020.00|| |
|9/23/2013||Emil E Hassan||Director||Sell||5,000||$49.00||$245,000.00|| |
|7/25/2013||David L Lassiter||VP||Sell||1,000||$49.94||$49,940.00|| |
|6/18/2013||Julia W Powell||VP||Sell||1,900||$48.12||$91,428.00|| |
|6/4/2013||Julia W Powell||VP||Sell||5,000||$48.15||$240,750.00|| |
|9/13/2012||Emil E Hassan||Director||Sell||4,197||$47.00||$197,259.00|| |
Headline Trends for National HealthCare (NYSEMKT:NHC)
Latest Headlines for National HealthCare (NYSEMKT:NHC)
Loading headlines, please wait.
National HealthCare (NHC) Chart for Monday, October, 23, 2017